Dr. Pedro Paul Diniz, DVM, PhD provides an update at the end of his first year looking for improved diagnostics for tick-borne disease using genetic sequencing.
Latest News
Research Update Mid-Year 1 for Identification of Genetic Risk Factors for Canine Epilepsy
Research update for Dr. Johnson’s work looking to identify possible genetic risk factors for canine epilepsy.
Research Update Mid-Year 1 for ketogenic MCT supplement therapy use in treating idiopathic canine epilepsy
Update on progress of Dr. Volk’s work looking at the benefits of using a ketogenic MCT supplement to aid in treatment of dogs with idiopathic canine epilepsy.
MAF Research Update Final for investigation of potential new treatment of Cushing’s syndrome
Final update of Dr. Galac’s research to investigate a new medical treatment for Cushing’s syndrome in dogs.
Research Update End-Year 3 for Biomarker to Detect Lymphoma Risk, Classify for Treatment and Predict Risk
End-year 3 update of Dr. Jeffery Bryan’s research to discover biomarkers for detection, classification, and treatment of B-cell lymphoma. Progress continues in the researcher’s efforts into this population of B cell lymphomas similar to the aggressive form seen in humans.
Final Summary Update End-Year 3 – Mapping Genetic Risk Factors for Canine Hip Dysplasia
Final summary update from the end of year 3 of research underway by Dr. Iivanainen of University of Helsinki to hopefully lead to a genetic test to aid breeders in controlling hip dysplasia. Research revealed 30 markers on eight different chromosomes that suggestively associated with the disease.
Research Update Mid-Year 1 for Enhanced Testing for the Diagnosis of Bartonellosis in Dogs
Update on progress with Dr. Breitschwerdt’s work on improving diagnostics for Bartonella.
Shine On Progress Update Mid-Year 2
The vision “to create a world where we no longer fear cancer” drives the work of Dr. Jaime Modiano and his colleagues in the Animal Cancer Care and Research Program of the University of Minnesota College of Veterinary Medicine. The “Shine On” study represents a turning point in their efforts to achieve this vision, by finding a way to prevent hemangiosarcoma, an aggressive, malignant tumor of blood vessel cells, in dogs.
Microphthalmia and Delayed Growth Syndrome
PARKER FORD, PA, February 1, 2017 – The Portuguese Water Dog Foundation is pleased to announce we have signed a Memorandum of Understanding (MOU) along with the Portuguese Water Dog Club of America to collaborate with AKC CHF to jointly fund research at the University of Pennsylvania (UPENN) – Section of Medical Genetics, Pediatrics and Reproduction to better characterize the clinical disorder of syndromic microphthalmia and delayed growth seen in the PWD, commonly known in our breed as Puppy Eye Syndrome (PES). Continue reading “Microphthalmia and Delayed Growth Syndrome”
One Year Update Measuring Drug Resistance in Dogs with T-cell Lymphoma
Update from the first year of work on MAF co-sponsored project D16CA-056, Measuring chemotherapy drug resistance in dogs with T-cell lymphoma; Paul R. Hess, DVM, PhD, North Carolina State University.
Continue reading “One Year Update Measuring Drug Resistance in Dogs with T-cell Lymphoma”
